Scientists Creating mRNA Biologics with Added Aluminum Adjuvant
Scientists at Boston Children’s Hospital in Massachusetts have developed an experimental mRNA biologic technology that they say produced longer-lasting immune responses in animal studies without the use of additional booster shots. The 2026 study was published in Nature Immunology.1 The research looked at a challenge in mRNA technology on how to make protection last longer […]
Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]
Australia’s COVID-19 Shot Injury Compensation System Criticized for Delays and Alleged Threats
Australia’s COVID-19 shot injury compensation system is under scrutiny, with injured individuals describing a slow, complex, and distressing process that has left many without timely support while their health and financial situations worsen.1 2 The federal government introduced the COVID-19 Vaccine Claims Scheme in 2021 as a “simple and quick” way to compensate people who […]
Canadian Government Overhauls Vaccine Injury Program
On Apr. 1, 2026, the Government of Canada assumed direct control of Canada’s vaccine injury compensation system, introducing changes aimed at improving how claims are processed and how support is delivered to vaccine injured individuals.1 The move followed an audit ordered by Health Minister Marjorie Michel in response to concerns about how the previous program […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
Poland, Romania Resist Brussels Court Order to Pay $2.2 Billion to Pfizer
A court in Belgium has ordered Poland and Romania to proceed with paying €1.9 billion ($2.2 billion) for purchasing mRNA COVID-19 shots from Pfizer, Inc. and BioNTech SE in a case brought by Pfizer three years ago. The lawsuit and court judgement has intensified a broader legal dispute over mRNA COVID shot contracts signed by […]